Purpose: Treatment non-adherence leads to negative therapeutic outcomes and financial burdens on the healthcare system. This study aims to compare the mean adherence scores among patients with five dermatological diseases and four treatment types and to identify the associated patient-related factors.
Patients and methods: This is a cross-sectional study conducted from January 2019 to August 2019. The questionnaire was distributed among patients attending the outpatient dermatology clinic at King Khalid University Hospital, Riyadh, Saudi Arabia. It included 2330 patients who were over 16 years old and diagnosed with any of the five dermatological diseases (psoriasis, chronic dermatitis, acne vulgaris, hair growth disorders, and vitiligo). The 12-item Medication Adherence Scale was used to quantify the mean adherence score.
Results: Patients with psoriasis or chronic dermatitis were less adherent to treatments than patients with acne vulgaris, hair growth disorder, or vitiligo. Oral treatment and phototherapy had higher mean adherence scores than injection or topical treatment. High adherence was found in female, single patients; those who did not feel stigmatized from using treatment; those who did not have bad experience with the treatment; those who did not suffer from forgetfulness; those who connected receiving treatment with a habit; those who did not lack treatment responsiveness; those who had an excellent relationship with a dermatologist; and patients with a lesion in an exposed area. Stepwise multiple linear regression was also used to identify the independent variables related to adherence score.
Conclusion: Psoriasis and chronic dermatitis patients had the lowest mean adherence scores. Patient who were on oral medication had the highest adherence score, while those on topical medication had the lowest score. The thoughtful consideration of factors associated with high adherence is important for optimal therapeutic outcomes.
Keywords: acne; adherence; dermatitis; psoriasis; treatment; vitiligo.
© 2019 Alsubeeh et al.
Conflict of interest statement
The author reports no conflicts of interest in this work.
Poor Adherence to Medication as Assessed by the Morisky Medication Adherence Scale-8 and Low Satisfaction With Treatment in 237 Psoriasis PatientsH Saeki et al. J Dermatol 42 (4), 367-72. PMID 25720544.Previously we assessed the medication adherence for oral and topical remedies by a translated Japanese version of the Morisky Medication Adherence Scale-8 (MMAS-8) togeth …
The Impact of Therapeutic Modalities on Patients With Atopic Dermatitis, Psoriasis and Vitiligo Treated With Phototherapy in the Jagiellonian University Outpatient ClinicK Englert et al. Pol Merkur Lekarski 46 (273), 125-129. PMID 30912521.Phototherapy constitutes an efficient, safe and accessible (in Poland and many other countries) method of therapy but there is still much to be discovered about the facto …
Topical Drug Delivery Systems in Dermatology: A Review of Patient Adherence IssuesX Tan et al. Expert Opin Drug Deliv 9 (10), 1263-71. PMID 22861153. - ReviewThe authors recommend some possible ways to improve topical medication adherence and provide some future research directions. Taking patient preference into consideration …
Medication Adherence, Healthcare Costs and Utilization Associated With Acne Drugs in Medicaid Enrollees With Acne VulgarisX Tan et al. Am J Clin Dermatol 14 (3), 243-51. PMID 23572294.Medication non-adherence is generally prevalent among young acne patients enrolled in Medicaid. The combination of a topical retinoid and an antibiotic agent may be a goo …
Pharmionics in Dermatology: A Review of Topical Medication AdherenceIA Lee et al. Am J Clin Dermatol 7 (4), 231-6. PMID 16901183. - ReviewThe objective of this article was to review patient adherence to topical medications and its relationship to health outcomes in dermatologic disease. To this end, MEDLINE …